携带目标病毒糖蛋白的仙台病毒颗粒用于诱导抗体
本研究开发了一种携带目标糖蛋白的仙台病毒(SeV)颗粒疫苗平台。构建的HIV-1 EnvF嵌合抗原可高效整合入SeV颗粒,并被广谱中和抗体识别,保留天然样功能结构。用表达HIV EnvF的复制缺陷型SeV及携带HIV EnvF的非感染性SeV颗粒免疫小鼠,可有效诱导抗HIV Env抗体;HTLV-1 EnvF也显示诱导抗HTLV-1 Env抗体的潜力。
要点
- HIV-1 EnvF嵌合抗原可高效整合入SeV颗粒并被广谱中和抗体识别。
- HIV-1AD8 EnvF可介导病毒进入细胞,该过程可被广谱中和抗体和进入抑制剂抑制。
- 携带HIV EnvF的SeV颗粒免疫小鼠可有效诱导抗HIV Env抗体。
核心结论
- 携带EnvF的SeV颗粒可作为诱导针对包膜病毒糖蛋白抗体的有前景的疫苗平台。
研究设计与样本
- 本研究构建了由HIV-1 Env胞外域和SeV F跨膜-胞质域组成的嵌合抗原HIV-1 EnvF,并制备了表达HIV EnvF的复制缺陷型SeV及携带HIV EnvF的非感染性SeV颗粒(NVP),在小鼠中进行免疫原性评价。
主要发现
- EnvF可高效整合入SeV病毒颗粒,并被包括靶向Env三聚体依赖性表位的35O22在内的抗HIV-1广谱中和单克隆抗体识别。
- HIV-1AD8 EnvF可介导病毒进入细胞,该过程可被抗HIV-1广谱中和抗体和HIV-1进入抑制剂抑制。
- 用表达HIV EnvF的复制缺陷型SeV及携带HIV EnvF的非感染性SeV颗粒免疫小鼠,可有效诱导抗HIV Env抗体。
- HTLV-1 EnvF也显示出有效诱导抗HTLV-1 Env抗体的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Induction of antibodies targeting viral glycoproteins is a key for the development of a vaccine against enveloped virus infection. Glycoproteins on the virion exhibiting native multimer structure may be a good immunogen to present antibody epitopes, but it is often difficult to prepare immunogenic inactivated virions. Preparation of soluble glycoprotein multimers has been attempted, while virus-like particles carrying target glycoproteins can be a more immunogenic antigen. In the present study, a target glycoprotein-embedded Sendai virus (SeV) particle was developed for induction of anti-virus antibodies. We constructed a chimeric antigen, HIV-1 EnvF, consisting of HIV-1 Env ectodomain and SeV F transmembrane-cytoplasmic domain, which was shown to be efficiently incorporated into the SeV virion. EnvF was recognized by anti-HIV-1 broadly-neutralizing monoclonal antibodies (bnAbs) including 35O22 that targets an Env trimer-dependent epitope. Analysis revealed that HIV-1AD8 EnvF can mediate viral entry into the cells, which is inhibited by anti-HIV-1 bnAbs and HIV-1 entry inhibitors, suggesting that the EnvF exhibits an HIV-1 Env native-like functional structure to present bnAb epitopes. Immunization of mice with replication-defective SeVs expressing HIV EnvF and non-infectious SeV particles (NVP) carrying HIV EnvF efficiently induced anti-HIV Env antibodies. HTLV-1 EnvF also showed the potential to efficiently induce anti-HTLV-1 Env antibodies. These results indicate that SeV particles carrying EnvF can be a promising vaccine platform for induction of antibodies targeting enveloped virus glycoproteins.
引用
- Ishii H, Nakamura-Hoshi M, Shu T, et al. Sendai virus particles carrying target virus glycoproteins for antibody induction. Vaccine. 2022. PMID: 35305826. doi:10.1016/j.vaccine.2022.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。